AdaptHealth Corp. $AHCO Shares Sold by Reinhart Partners LLC.

Reinhart Partners LLC. lowered its holdings in AdaptHealth Corp. (NASDAQ:AHCO) by 26.4% in the second quarter, HoldingsChannel reports. The firm owned 7,415,537 shares of the company’s stock after selling 2,666,446 shares during the period. Reinhart Partners LLC. owned about 0.05% of AdaptHealth worth $77,270,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. SG Americas Securities LLC raised its position in shares of AdaptHealth by 386.3% in the 4th quarter. SG Americas Securities LLC now owns 78,141 shares of the company’s stock valued at $778,000 after purchasing an additional 62,073 shares in the last quarter. Kennedy Capital Management LLC boosted its stake in shares of AdaptHealth by 15.2% during the 4th quarter. Kennedy Capital Management LLC now owns 2,408,038 shares of the company’s stock valued at $23,984,000 after buying an additional 317,900 shares during the last quarter. Arrowstreet Capital Limited Partnership grew its position in shares of AdaptHealth by 87.7% during the first quarter. Arrowstreet Capital Limited Partnership now owns 847,085 shares of the company’s stock worth $10,080,000 after buying an additional 395,668 shares in the last quarter. Principal Financial Group Inc. grew its position in shares of AdaptHealth by 25.1% during the first quarter. Principal Financial Group Inc. now owns 2,784,316 shares of the company’s stock worth $33,133,000 after buying an additional 558,357 shares in the last quarter. Finally, Hudson Edge Investment Partners Inc. bought a new stake in shares of AdaptHealth in the fourth quarter worth $614,000. Hedge funds and other institutional investors own 82.67% of the company’s stock.

Insider Buying and Selling at AdaptHealth

In related news, insider Russell E. Schuster III sold 11,275 shares of the firm’s stock in a transaction that occurred on Monday, June 1st. The stock was sold at an average price of $10.06, for a total value of $113,426.50. Following the sale, the insider owned 136,538 shares of the company’s stock, valued at approximately $1,373,572.28. This trade represents a 7.63% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 1.95% of the company’s stock.

AdaptHealth Stock Performance

Shares of NASDAQ AHCO opened at $5.69 on Friday. The company has a quick ratio of 0.71, a current ratio of 1.12 and a debt-to-equity ratio of 1.37. The firm’s 50-day moving average price is $9.96 and its two-hundred day moving average price is $10.55. AdaptHealth Corp. has a 52-week low of $5.66 and a 52-week high of $13.43. The stock has a market capitalization of $773.33 million, a P/E ratio of -3.33, a P/E/G ratio of 0.31 and a beta of 1.47.

Wall Street Analysts Forecast Growth

Several analysts recently issued reports on AHCO shares. Wall Street Zen cut shares of AdaptHealth from a “buy” rating to a “hold” rating in a report on Saturday. Truist Financial decreased their price objective on shares of AdaptHealth from $14.00 to $9.00 and set a “buy” rating for the company in a report on Wednesday. Weiss Ratings reissued a “sell (d)” rating on shares of AdaptHealth in a research report on Friday, May 22nd. UBS Group cut their target price on shares of AdaptHealth from $14.00 to $10.00 and set a “buy” rating on the stock in a research note on Thursday. Finally, Royal Bank Of Canada reduced their price target on shares of AdaptHealth from $15.00 to $8.00 and set an “outperform” rating on the stock in a research report on Thursday. Seven investment analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $10.29.

About AdaptHealth

AdaptHealth, Inc operates as a leading provider of home medical equipment (HME) and related services in the United States. The company focuses on delivering respiratory care, mobility solutions and bathroom safety products to patients with chronic and acute medical needs. Through its comprehensive service offerings, AdaptHealth aims to enhance quality of life and clinical outcomes for patients who require long-term support outside of a hospital setting.

The company’s respiratory portfolio includes products such as continuous positive airway pressure (CPAP) devices, oxygen concentrators, ventilators, and associated supplies for patients with sleep apnea, COPD and other pulmonary conditions.